The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients…
Inside Google’s quantum computing lab in Santa Barbara, California. CNBC Quantum computing stocks are wrapping up a big week of double-digit gains. Shares of Rigetti Computing, D-Wave Quantum and Quantum Computing have surged more than 20%. Rigetti and D-Wave Quantum have more than doubled and tripled, respectively, since the start of the year. Arqit Quantum…
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty Images Swiss pharmaceutical firm Roche is targeting becoming a top three obesity player globally, posing a potential rival to heavyweights Novo Nordisk and Eli Lilly as it advances one of its experimental weight-loss drugs to…
The Bank of England (BOE) in the City of London, UK, on Monday, Dec. 16, 2024. Jason Alden | Bloomberg | Getty Images LONDON — European stocks opened higher on Thursday, as traders evaluated the U.S. Federal Reserve’s rate cut on Wednesday. The pan-European Stoxx 600 was 0.5% higher by 8:18 a.m. in London (3:18…
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk said Wednesday that late-stage trial results…
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments — the first in a string of new…
Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medications: pills. Both companies expect to launch oral obesity drugs in the U.S. next year, once regulators approve them. Daily pills could introduce more people to GLP-1s, the class of medicine that’s best known for weekly shots. But…
Jennifer Johnson, founder of True Fashionistas, Florida’s largest clothing reseller, started noticing something unusual about a year ago. Suddenly, once difficult-to-find larger sizes were becoming more common in the batches of clothing arriving for resale. Since then, the trickle has become a torrent. Johnson said that historically, her store has been overloaded with extra smalls and…
LONDON — European stocks opened higher on Wednesday as investors assessed the latest trade news, corporate earnings and inflation data. The pan-European Stoxx 600 was 0.5% higher by 11:56 a.m. in London (6:56 a.m. ET), with most sectors and all major regional bourses in positive territory. Looking at individual stocks, shares of Danish pharmaceutical giant…
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images Danish pharmaceutical giant Novo Nordisk on Wednesday announced plans to cut roughly 9,000 roles. “Novo Nordisk today announced a company-wide transformation to simplify its organisation, improve the speed of decision-making, and reallocate resources towards the…
